Russell Barton
Chief Operating Officer chez ACUMEN PHARMACEUTICALS, INC.
Fortune : 392 311 $ au 31/03/2024
Profil
Russell Barton is currently the Director of Clinical Operations at AgeneBio, Inc., the Chief Operating Officer at Acumen Pharmaceuticals, Inc., and the President & Consultant at Pharma Sagacity Consulting LLC.
He previously worked as the Chief Operating Officer at Eli Lilly & Co. Barton received his undergraduate degree from Illinois State University and his graduate degree from Purdue University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 18/01/2024 | 96 867 ( 0,16% ) | 392 311 $ | 31/03/2024 |
Postes actifs de Russell Barton
| Sociétés | Poste | Début |
|---|---|---|
| ACUMEN PHARMACEUTICALS, INC. | Chief Operating Officer | 01/04/2019 |
AgeneBio, Inc.
 AgeneBio, Inc. BiotechnologyHealth Technology AgeneBio, Inc. develops an innovative therapeutics for unserved patients afflicted with neurological and psychiatric diseases to preserve and restore brain function. It research focused on cognitive neuroscience and the neurobiology of the aging brain with most advanced clinical program targets amnestic mild cognitive impairment (aMCI), the symptomatic, pre-dementia stage of Alzheimer’s. The company was founded by Michela Gallagher in 2008 and is headquartered in Baltimore, MD. | Chief Tech/Sci/R&D Officer | 01/10/2019 |
| Pharma Sagacity Consulting LLC | President | 01/01/2018 |
Anciens postes connus de Russell Barton
| Sociétés | Poste | Fin |
|---|---|---|
| ELI LILLY AND COMPANY | Chief Operating Officer | - |
Formation de Russell Barton
| Illinois State University | Undergraduate Degree |
| Purdue University | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| ELI LILLY AND COMPANY | Health Technology |
| ACUMEN PHARMACEUTICALS, INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
AgeneBio, Inc.
AgeneBio, Inc. BiotechnologyHealth Technology AgeneBio, Inc. develops an innovative therapeutics for unserved patients afflicted with neurological and psychiatric diseases to preserve and restore brain function. It research focused on cognitive neuroscience and the neurobiology of the aging brain with most advanced clinical program targets amnestic mild cognitive impairment (aMCI), the symptomatic, pre-dementia stage of Alzheimer’s. The company was founded by Michela Gallagher in 2008 and is headquartered in Baltimore, MD. | Health Technology |
| Pharma Sagacity Consulting LLC |
